Literature DB >> 30075281

Chronic in vivo angiotensin II administration differentially modulates the slow delayed rectifier channels in atrial and ventricular myocytes.

Dimitar P Zankov1, Fadi N Salloum2, Min Jiang1, Gea-Ny Tseng3.   

Abstract

BACKGROUND: In the heart, slow delayed rectifier channels provide outward currents (IKs) for action potential (AP) repolarization in a region- and context-dependent manner. In diseased hearts, chronic elevation of angiotensin II (Ang II) may remodel IKs in a region-dependent manner, contributing to atrial and ventricular arrhythmias of different mechanisms.
OBJECTIVE: The purpose of this study was to study whether/how chronic in vivo Ang II administration remodels IKs in atrial and ventricular myocytes.
METHODS: We used the guinea pig (GP) model whose myocytes express robust IKs. GPs were implanted with minipumps containing Ang II or vehicle. Treatment continued for 4-6 weeks. We used patch clamp, immunofluorescence/confocal microscopy, and immunoblots to evaluate changes in IKs function and to explore the underlying mechanisms.
RESULTS: We confirmed the pathologic state of the heart after chronic Ang II treatment. IKs density was increased in atrial myocytes but decreased in ventricular myocytes in Ang II- vs vehicle-treated animals. The former was correlated with an increase in KCNQ1/KCNE1 colocalization in myocyte periphery, whereas the latter was correlated with a decrease in KCNQ1 protein level. Interestingly, these changes in IKs were not translated into expected alterations in AP duration or plateau voltage, indicating that other currents were involved. In atrial myocytes from Ang II-treated animals, the L-type Ca channel current was increased, contributing to AP plateau elevation and AP duration prolongation.
CONCLUSION: IKs is differentially modulated by chronic in vivo Ang II administration between atrial and ventricular myocytes. Other currents remodeled by Ang II treatment also contribute to changes in action potentials.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin II; Angiotensin receptor type I; Arrhythmia; Repolarization reserve; Slow delayed rectifier current

Year:  2018        PMID: 30075281      PMCID: PMC6321789          DOI: 10.1016/j.hrthm.2018.07.036

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  20 in total

1.  In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both.

Authors:  Ricardo Caballero; Marta González de la Fuente; Ricardo Gómez; Adriana Barana; Irene Amorós; Pablo Dolz-Gaitón; Lourdes Osuna; Jesús Almendral; Felipe Atienza; Francisco Fernández-Avilés; Ana Pita; Jorge Rodríguez-Roda; Angel Pinto; Juan Tamargo; Eva Delpón
Journal:  J Am Coll Cardiol       Date:  2010-05-25       Impact factor: 24.094

2.  O-glycosylation of the cardiac I(Ks) complex.

Authors:  Kshama D Chandrasekhar; Anatoli Lvov; Cecile Terrenoire; Grace Y Gao; Robert S Kass; William R Kobertz
Journal:  J Physiol       Date:  2011-06-13       Impact factor: 5.182

3.  Electrical remodeling in a canine model of ischemic cardiomyopathy.

Authors:  Xian-Sheng Liu; Min Jiang; Mei Zhang; Daniel Tang; Henry F Clemo; Robert S D Higgins; Gea-Ny Tseng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-08-18       Impact factor: 4.733

4.  Quantification of repolarization reserve to understand interpatient variability in the response to proarrhythmic drugs: a computational analysis.

Authors:  Amrita X Sarkar; Eric A Sobie
Journal:  Heart Rhythm       Date:  2011-06-07       Impact factor: 6.343

5.  Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.

Authors:  Norbert Jost; László Virág; Miklós Bitay; János Takács; Csaba Lengyel; Péter Biliczki; Zsolt Nagy; Gábor Bogáts; David A Lathrop; Julius G Papp; András Varró
Journal:  Circulation       Date:  2005-08-29       Impact factor: 29.690

6.  Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation.

Authors:  Vijaykumar S Kasi; Hong D Xiao; Lijuan L Shang; Shahriar Iravanian; Jonathan Langberg; Emily A Witham; Zhe Jiao; Carlos J Gallego; Kenneth E Bernstein; Samuel C Dudley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-02       Impact factor: 4.733

7.  Location of KCNE1 relative to KCNQ1 in the I(KS) potassium channel by disulfide cross-linking of substituted cysteines.

Authors:  David Y Chung; Priscilla J Chan; John R Bankston; Lin Yang; Guoxia Liu; Steven O Marx; Arthur Karlin; Robert S Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-08       Impact factor: 11.205

8.  Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.

Authors:  Fadi N Salloum; Antonio Abbate; Anindita Das; Jon-Erik Houser; Colin A Mudrick; Ian Z Qureshi; Nicholas N Hoke; Sion K Roy; William R Brown; Shashi Prabhakar; Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-25       Impact factor: 4.733

9.  Characterization of recombinant human cardiac KCNQ1/KCNE1 channels (I (Ks)) stably expressed in HEK 293 cells.

Authors:  Ming-Qing Dong; Chu-Pak Lau; Zhan Gao; Gea-Ny Tseng; Gui-Rong Li
Journal:  J Membr Biol       Date:  2006-08-14       Impact factor: 2.426

10.  Angiotensin II (AT1) receptors and NADPH oxidase regulate Cl- current elicited by beta1 integrin stretch in rabbit ventricular myocytes.

Authors:  David M Browe; Clive M Baumgarten
Journal:  J Gen Physiol       Date:  2004-09       Impact factor: 4.086

View more
  2 in total

1.  Pharmacological suppression of Nedd4-2 rescues the reduction of Kv11.1 channels in pathological cardiac hypertrophy.

Authors:  Hua Zhang; Tian Fu; Jinglei Sun; Sihao Zou; Suhua Qiu; Jiali Zhang; Shi Su; Chenxia Shi; De-Pei Li; Yanfang Xu
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

Review 2.  Anti-arrhythmic properties of non-antiarrhythmic medications.

Authors:  Emmanuel Ato Williams; Vincenzo Russo; Sergio Ceraso; Dhiraj Gupta; Richard Barrett-Jolley
Journal:  Pharmacol Res       Date:  2020-03-23       Impact factor: 7.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.